2024-03-05 10:46:04 ET
SOPHiA GENETICS SA (SOPH)
Q4 2023 Earnings Conference Call
March 05, 2024, 08:00 AM ET
Company Participants
Kellen Sanger - Head, Strategy & Investor Relations
Jurgi Camblong - Co-Founder & Chief Executive Officer
Ross Muken - Chief Executive Officer & Chief Operating Officer
Conference Call Participants
Dan Brennan - TD Cowen
Tejas Savant - Morgan Stanley
Conor McNamara - RBC Capital Markets
Presentation
Operator
Good morning. My name is Drew, and I will be your conference operator today. At this time, I would like to welcome everyone to the SOPHiA GENETICS' Fourth Quarter and Full Year 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Kellen Sanger, SOPHiA GENETICS' Head of Strategy and Investor Relations. You may begin.
Kellen Sanger
Thank you, and good morning, everyone. Welcome to the SOPHiA GENETICS' fourth quarter and full year 2023 earnings conference call.
Joining me today to discuss our results are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer, and Ross Muken, our Chief Financial Officer and Chief Operating Officer.
I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties and factors that could cause results to differ appears in the press release SOPHiA GENETICS issued today and in the documents and reports filed by SOPHiA GENETICS from time to time with the Securities and Exchange Commission....
Read the full article on Seeking Alpha
For further details see:
SOPHiA GENETICS SA (SOPH) Q4 2023 Earnings Call Transcript